MedPath

Controlled hypotension due to magnesium sulfate and remifentanil

Phase 3
Conditions
Instability of Lumbar Spine.
Dislocation of other & unspecified parts of lumbar spine & pelvis
Registration Number
IRCT201111138091N1
Lead Sponsor
Research vice-chancellor of Medicine faculty, Tehran university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion criteria include:
Individuals between 20-60 years old, candidate for PSF surgery, ASA I & II physical status, signing informed consent of study
Exclusion Criteria includs:
Allergic reaction to drugs, Liver, renal, cardiovascular failure, Ventricular and atrial arythmia and conduction heart disorders, Opioid consumption and drug abuse, Chronic therapy with opioids, NSAIDs and calcium channel blockers

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean arterial pressure. Timepoint: Continuous monitoring. Method of measurement: Invasive blood pressure monitorig with transducer and monitoring device.;Blood loss. Timepoint: During operation. Method of measurement: Calculating the amount of blood in the suction, surgical field and towels in cc.
Secondary Outcome Measures
NameTimeMethod
Prevalence of transfusion in two groups. Timepoint: End of surgery. Method of measurement: Recording patients who need for transfusion and number of blood packs.;Arrhythmia. Timepoint: During operation. Method of measurement: Continuous ECG monitoring.;Bradycardia. Timepoint: During operation. Method of measurement: Continuous ECG monitoring.;Hypotension. Timepoint: During operation. Method of measurement: Continuous IBP monitoring.;Prevalence of need for TNG administration. Timepoint: Throughout the operation. Method of measurement: Recording patients who need TNG for controlling blood pressure.
© Copyright 2025. All Rights Reserved by MedPath